149 related articles for article (PubMed ID: 16405404)
1. A case of hypersensitivity syndrome induced by methimazole for Graves' disease.
Ozaki N; Miura Y; Sakakibara A; Oiso Y
Thyroid; 2005 Dec; 15(12):1333-6. PubMed ID: 16405404
[TBL] [Abstract][Full Text] [Related]
2. Drug-induced hypersensitivity syndrome due to cyanamide associated with multiple reactivation of human herpesviruses.
Mitani N; Aihara M; Yamakawa Y; Yamada M; Itoh N; Mizuki N; Ikezawa Z
J Med Virol; 2005 Mar; 75(3):430-4. PubMed ID: 15648066
[TBL] [Abstract][Full Text] [Related]
3. Acute pancreatitis induced by methimazole in a patient with Graves' disease.
Yang M; Qu H; Deng HC
Thyroid; 2012 Jan; 22(1):94-6. PubMed ID: 22136208
[TBL] [Abstract][Full Text] [Related]
4. Reactivation of human herpesvirus (HHV) family members other than HHV-6 in drug-induced hypersensitivity syndrome.
Seishima M; Yamanaka S; Fujisawa T; Tohyama M; Hashimoto K
Br J Dermatol; 2006 Aug; 155(2):344-9. PubMed ID: 16882173
[TBL] [Abstract][Full Text] [Related]
5. Use of antihistamines after serious allergic reaction to methimazole in pediatric Graves' disease.
Toderian AB; Lawson ML
Pediatrics; 2014 May; 133(5):e1401-4. PubMed ID: 24777217
[TBL] [Abstract][Full Text] [Related]
6. Methimazole-induced agranulocytosis in patients with Graves' disease is more frequent with an initial dose of 30 mg daily than with 15 mg daily.
Takata K; Kubota S; Fukata S; Kudo T; Nishihara E; Ito M; Amino N; Miyauchi A
Thyroid; 2009 Jun; 19(6):559-63. PubMed ID: 19445623
[TBL] [Abstract][Full Text] [Related]
7. Drug-induced hypersensitivity syndrome due to carbapenem antibiotics.
Goto M; Shimizu F; Takeo N; Okamoto O; Katagiri K; Ikewaki J; Ogata M; Kadota J; Fujiwara S
J Dermatol; 2010 Apr; 37(4):374-7. PubMed ID: 20507410
[TBL] [Abstract][Full Text] [Related]
8. In vitro immunoreactivity to propylthiouracil, methimazole, and carbimazole in patients with Graves' disease: a possible cause of antithyroid drug-induced agranulocytosis.
Wall JR; Fang SL; Kuroki T; Ingbar SH; Braverman LE
J Clin Endocrinol Metab; 1984 May; 58(5):868-72. PubMed ID: 6200492
[TBL] [Abstract][Full Text] [Related]
9. Drug-induced hypersensitivity syndrome due to mexiletine hydrochloride associated with reactivation of human herpesvirus 7.
Yagami A; Yoshikawa T; Asano Y; Koie S; Shiohara T; Matsunaga K
Dermatology; 2006; 213(4):341-4. PubMed ID: 17135743
[TBL] [Abstract][Full Text] [Related]
10. Methimazole-induced acute pancreatitis: a case report.
Kikuchi I; Miyata N; Yoshimura Y; Miyamoto K; Tachikawa N
Clin J Gastroenterol; 2019 Jun; 12(3):239-242. PubMed ID: 30474825
[TBL] [Abstract][Full Text] [Related]
11. Acute pancreatitis and parotitis induced by methimazole in a patient with Graves' disease.
Taguchi M; Yokota M; Koyano H; Endo Y; Ozawa Y
Clin Endocrinol (Oxf); 1999 Nov; 51(5):667-70. PubMed ID: 10594530
[TBL] [Abstract][Full Text] [Related]
12. A case of type 1 diabetes followed by methimazole-induced hypersensitivity syndrome.
Ozaki N; Miura Y; Oiso Y
Diabetes Care; 2006 May; 29(5):1179-80. PubMed ID: 16644665
[No Abstract] [Full Text] [Related]
13. The relation of initial methimazole dose to the incidence of methimazole-induced agranulocytosis in patients with Graves' disease.
Tsuboi K; Ueshiba H; Shimojo M; Ishikawa M; Watanabe N; Nagasawa K; Yuasa R; Yoshino G
Endocr J; 2007 Feb; 54(1):39-43. PubMed ID: 17053291
[TBL] [Abstract][Full Text] [Related]
14. Comparison of single daily dose of methimazole and propylthiouracil in the treatment of Graves' hyperthyroidism.
He CT; Hsieh AT; Pei D; Hung YJ; Wu LY; Yang TC; Lian WC; Huang WS; Kuo SW
Clin Endocrinol (Oxf); 2004 Jun; 60(6):676-81. PubMed ID: 15163329
[TBL] [Abstract][Full Text] [Related]
15. Benefit of short-term iodide supplementation to antithyroid drug treatment of thyrotoxicosis due to Graves' disease.
Takata K; Amino N; Kubota S; Sasaki I; Nishihara E; Kudo T; Ito M; Fukata S; Miyauchi A
Clin Endocrinol (Oxf); 2010 Jun; 72(6):845-50. PubMed ID: 19912243
[TBL] [Abstract][Full Text] [Related]
16. Human herpes virus 6 encephalitis in allopurinol-induced hypersensitivity syndrome.
Masaki T; Fukunaga A; Tohyama M; Koda Y; Okuda S; Maeda N; Kanda F; Yasukawa M; Hashimoto K; Horikawa T; Ueda M
Acta Derm Venereol; 2003; 83(2):128-31. PubMed ID: 12735642
[TBL] [Abstract][Full Text] [Related]
17. A prospective randomized trial of antithyroid drug dose in Graves' disease therapy. European Multicenter Study Group on Antithyroid Drug Treatment.
Reinwein D; Benker G; Lazarus JH; Alexander WD
J Clin Endocrinol Metab; 1993 Jun; 76(6):1516-21. PubMed ID: 8501160
[TBL] [Abstract][Full Text] [Related]
18. Occupational trichloroethylene hypersensitivity syndrome with human herpesvirus-6 and cytomegalovirus reactivation.
Watanabe H; Tohyama M; Kamijima M; Nakajima T; Yoshida T; Hashimoto K; Iijima M
Dermatology; 2010 Aug; 221(1):17-22. PubMed ID: 20407216
[TBL] [Abstract][Full Text] [Related]
19. Methimazole-induced aplastic anemia caused by hypocellular bone marrow with plasmacytosis.
Yamamoto A; Katayama Y; Tomiyama K; Hosoai H; Hirata F; Kimura F; Fujita K; Yasuda H
Thyroid; 2004 Mar; 14(3):231-5. PubMed ID: 15072706
[TBL] [Abstract][Full Text] [Related]
20. Polyarthritis caused by methimazole in two Japanese patients with graves' disease.
Nihei H; Tada H; Naruse Y; Izawa M; Kato M; Okuno H; Nakamura A; Ishizu K; Hamajima T; Tajima T
J Clin Res Pediatr Endocrinol; 2013; 5(4):270-2. PubMed ID: 24379039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
